Avanos Medical (AVNS) Share-based Compensation (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Share-based Compensation data on file, last reported at $3.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 2.63% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $12.5 million (down 10.71% YoY), and the FY2025 full-year result was $12.6 million, down 8.7% from the prior year.
• Share-based Compensation improved to $3.7 million in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q3 2022 to a low of $1.2 million in Q4 2025.
• A 5-year average of $3.6 million and a median of $3.8 million in 2022 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 34.62% in 2025, while the deepest fall reached 68.42% in 2025.
• Tracing AVNS's Share-based Compensation over 5 years: stood at $4.0 million in 2022, then changed by 0.0% to $4.0 million in 2023, then slipped by 5.0% to $3.8 million in 2024, then plunged by 68.42% to $1.2 million in 2025, then surged by 208.33% to $3.7 million in 2026.
• Business Quant data shows AVNS's Share-based Compensation at $3.7 million in Q1 2026, $1.2 million in Q4 2025, and $3.5 million in Q3 2025.